Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
Men present more frequently with severe manifestations of coronavirus disease 2019 (COVID-19) and are at higher risk for death. The underlying mechanisms for these differences between female and male individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are insuffici...
Gespeichert in:
| Veröffentlicht in: | Immunity (Cambridge, Mass.) Mass.), 2020-09, Vol.53 (3), p.487-495 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 495 |
|---|---|
| container_issue | 3 |
| container_start_page | 487 |
| container_title | Immunity (Cambridge, Mass.) |
| container_volume | 53 |
| creator | Bunders, Madeleine J. Altfeld, Marcus |
| description | Men present more frequently with severe manifestations of coronavirus disease 2019 (COVID-19) and are at higher risk for death. The underlying mechanisms for these differences between female and male individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are insufficiently understood. However, studies from other viral infections have shown that females can mount stronger immune responses against viruses than males. Emerging knowledge on the basic biological pathways that underlie differences in immune responses between women and men needs to be incorporated into research efforts on SARS-CoV-2 pathogenesis and pathology to identify targets for therapeutic interventions aimed at enhancing antiviral immune function and lung airway resilience while reducing pathogenic inflammation in COVID-19.
Clinical manifestations of SARS-CoV-2 infection differ between women and men, with men presenting more frequently with severe COVID-19. We review the impact of sex differences in immunity for these differences in COVID-19 and discuss the implications for clinical interventions. |
| doi_str_mv | 10.1016/j.immuni.2020.08.003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7430299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1074761320303368</els_id><sourcerecordid>2442830439</sourcerecordid><originalsourceid>FETCH-LOGICAL-c613t-7d2006c4e7180b000971dd92fb100ec8b3739a320877158bd90b630d17df1ea23</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhSMEoqXwDxCyxKabhOtH4mSDVE2BjlQJxBS2luPczHg0sQc7GdF_j9Npy2PBypZ87jn3-Muy1xQKCrR6ty3sMEzOFgwYFFAXAPxJdkqhkbmgNTyd71LksqL8JHsR4xaAirKB59kJZ3XJS1GeZn457HfW6NF6F4nvyQp_kkvb9xjQGYzEOrK8yxlvSe8DWV18XeUL_z1n5IseN36NDqONRLuOXKbb2s0uNxsMeo_TaA1ZuhHDAd1dxMvsWa93EV_dn2fZt48fbhZX-fXnT8vFxXVu0rpjLjsGUBmBMjVpAVIp2nUN61sKgKZuueSN5gxqKWlZt10DbcWho7LrKWrGz7L3R9_91A7YmRQf9E7tgx10uFVeW_X3i7MbtfYHJQUH1jTJ4PzeIPgfE8ZRDTYa3O20Qz9FxQSvK1lWtUzSt_9It34KLtVLKsFqDoLPhuKoMsHHGLB_XIaCmomqrToSVTNRBbVKRNPYmz-LPA49IPzdFNN3HiwGFY2d2XU2oBlV5-3_E34Bi5S0IQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2442830439</pqid></control><display><type>article</type><title>Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Cell Press Free Archives</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Bunders, Madeleine J. ; Altfeld, Marcus</creator><creatorcontrib>Bunders, Madeleine J. ; Altfeld, Marcus</creatorcontrib><description>Men present more frequently with severe manifestations of coronavirus disease 2019 (COVID-19) and are at higher risk for death. The underlying mechanisms for these differences between female and male individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are insufficiently understood. However, studies from other viral infections have shown that females can mount stronger immune responses against viruses than males. Emerging knowledge on the basic biological pathways that underlie differences in immune responses between women and men needs to be incorporated into research efforts on SARS-CoV-2 pathogenesis and pathology to identify targets for therapeutic interventions aimed at enhancing antiviral immune function and lung airway resilience while reducing pathogenic inflammation in COVID-19.
Clinical manifestations of SARS-CoV-2 infection differ between women and men, with men presenting more frequently with severe COVID-19. We review the impact of sex differences in immunity for these differences in COVID-19 and discuss the implications for clinical interventions.</description><identifier>ISSN: 1074-7613</identifier><identifier>ISSN: 1097-4180</identifier><identifier>EISSN: 1097-4180</identifier><identifier>DOI: 10.1016/j.immuni.2020.08.003</identifier><identifier>PMID: 32853545</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Betacoronavirus - immunology ; Coronaviridae ; Coronavirus Infections - immunology ; Coronaviruses ; COVID-19 ; Female ; Gender aspects ; Gender differences ; Humans ; Immune response ; immune responses ; Immunity, Innate - immunology ; Male ; Men ; Mortality ; Pandemics ; Pathogenesis ; Pneumonia, Viral - immunology ; Review ; SARS-CoV-2 ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Sex Characteristics ; Sex differences ; Target recognition ; Therapeutic applications ; tissue regeneration ; Viral diseases ; Viral infections ; Viruses</subject><ispartof>Immunity (Cambridge, Mass.), 2020-09, Vol.53 (3), p.487-495</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><rights>2020. Elsevier Inc.</rights><rights>2020 Elsevier Inc. 2020 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c613t-7d2006c4e7180b000971dd92fb100ec8b3739a320877158bd90b630d17df1ea23</citedby><cites>FETCH-LOGICAL-c613t-7d2006c4e7180b000971dd92fb100ec8b3739a320877158bd90b630d17df1ea23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.immuni.2020.08.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32853545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bunders, Madeleine J.</creatorcontrib><creatorcontrib>Altfeld, Marcus</creatorcontrib><title>Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions</title><title>Immunity (Cambridge, Mass.)</title><addtitle>Immunity</addtitle><description>Men present more frequently with severe manifestations of coronavirus disease 2019 (COVID-19) and are at higher risk for death. The underlying mechanisms for these differences between female and male individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are insufficiently understood. However, studies from other viral infections have shown that females can mount stronger immune responses against viruses than males. Emerging knowledge on the basic biological pathways that underlie differences in immune responses between women and men needs to be incorporated into research efforts on SARS-CoV-2 pathogenesis and pathology to identify targets for therapeutic interventions aimed at enhancing antiviral immune function and lung airway resilience while reducing pathogenic inflammation in COVID-19.
Clinical manifestations of SARS-CoV-2 infection differ between women and men, with men presenting more frequently with severe COVID-19. We review the impact of sex differences in immunity for these differences in COVID-19 and discuss the implications for clinical interventions.</description><subject>Betacoronavirus - immunology</subject><subject>Coronaviridae</subject><subject>Coronavirus Infections - immunology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Female</subject><subject>Gender aspects</subject><subject>Gender differences</subject><subject>Humans</subject><subject>Immune response</subject><subject>immune responses</subject><subject>Immunity, Innate - immunology</subject><subject>Male</subject><subject>Men</subject><subject>Mortality</subject><subject>Pandemics</subject><subject>Pathogenesis</subject><subject>Pneumonia, Viral - immunology</subject><subject>Review</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Sex Characteristics</subject><subject>Sex differences</subject><subject>Target recognition</subject><subject>Therapeutic applications</subject><subject>tissue regeneration</subject><subject>Viral diseases</subject><subject>Viral infections</subject><subject>Viruses</subject><issn>1074-7613</issn><issn>1097-4180</issn><issn>1097-4180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAUhSMEoqXwDxCyxKabhOtH4mSDVE2BjlQJxBS2luPczHg0sQc7GdF_j9Npy2PBypZ87jn3-Muy1xQKCrR6ty3sMEzOFgwYFFAXAPxJdkqhkbmgNTyd71LksqL8JHsR4xaAirKB59kJZ3XJS1GeZn457HfW6NF6F4nvyQp_kkvb9xjQGYzEOrK8yxlvSe8DWV18XeUL_z1n5IseN36NDqONRLuOXKbb2s0uNxsMeo_TaA1ZuhHDAd1dxMvsWa93EV_dn2fZt48fbhZX-fXnT8vFxXVu0rpjLjsGUBmBMjVpAVIp2nUN61sKgKZuueSN5gxqKWlZt10DbcWho7LrKWrGz7L3R9_91A7YmRQf9E7tgx10uFVeW_X3i7MbtfYHJQUH1jTJ4PzeIPgfE8ZRDTYa3O20Qz9FxQSvK1lWtUzSt_9It34KLtVLKsFqDoLPhuKoMsHHGLB_XIaCmomqrToSVTNRBbVKRNPYmz-LPA49IPzdFNN3HiwGFY2d2XU2oBlV5-3_E34Bi5S0IQ</recordid><startdate>20200915</startdate><enddate>20200915</enddate><creator>Bunders, Madeleine J.</creator><creator>Altfeld, Marcus</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200915</creationdate><title>Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions</title><author>Bunders, Madeleine J. ; Altfeld, Marcus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c613t-7d2006c4e7180b000971dd92fb100ec8b3739a320877158bd90b630d17df1ea23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Betacoronavirus - immunology</topic><topic>Coronaviridae</topic><topic>Coronavirus Infections - immunology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Female</topic><topic>Gender aspects</topic><topic>Gender differences</topic><topic>Humans</topic><topic>Immune response</topic><topic>immune responses</topic><topic>Immunity, Innate - immunology</topic><topic>Male</topic><topic>Men</topic><topic>Mortality</topic><topic>Pandemics</topic><topic>Pathogenesis</topic><topic>Pneumonia, Viral - immunology</topic><topic>Review</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Sex Characteristics</topic><topic>Sex differences</topic><topic>Target recognition</topic><topic>Therapeutic applications</topic><topic>tissue regeneration</topic><topic>Viral diseases</topic><topic>Viral infections</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bunders, Madeleine J.</creatorcontrib><creatorcontrib>Altfeld, Marcus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Immunity (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bunders, Madeleine J.</au><au>Altfeld, Marcus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions</atitle><jtitle>Immunity (Cambridge, Mass.)</jtitle><addtitle>Immunity</addtitle><date>2020-09-15</date><risdate>2020</risdate><volume>53</volume><issue>3</issue><spage>487</spage><epage>495</epage><pages>487-495</pages><issn>1074-7613</issn><issn>1097-4180</issn><eissn>1097-4180</eissn><abstract>Men present more frequently with severe manifestations of coronavirus disease 2019 (COVID-19) and are at higher risk for death. The underlying mechanisms for these differences between female and male individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are insufficiently understood. However, studies from other viral infections have shown that females can mount stronger immune responses against viruses than males. Emerging knowledge on the basic biological pathways that underlie differences in immune responses between women and men needs to be incorporated into research efforts on SARS-CoV-2 pathogenesis and pathology to identify targets for therapeutic interventions aimed at enhancing antiviral immune function and lung airway resilience while reducing pathogenic inflammation in COVID-19.
Clinical manifestations of SARS-CoV-2 infection differ between women and men, with men presenting more frequently with severe COVID-19. We review the impact of sex differences in immunity for these differences in COVID-19 and discuss the implications for clinical interventions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32853545</pmid><doi>10.1016/j.immuni.2020.08.003</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1074-7613 |
| ispartof | Immunity (Cambridge, Mass.), 2020-09, Vol.53 (3), p.487-495 |
| issn | 1074-7613 1097-4180 1097-4180 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7430299 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; Cell Press Free Archives; EZB-FREE-00999 freely available EZB journals |
| subjects | Betacoronavirus - immunology Coronaviridae Coronavirus Infections - immunology Coronaviruses COVID-19 Female Gender aspects Gender differences Humans Immune response immune responses Immunity, Innate - immunology Male Men Mortality Pandemics Pathogenesis Pneumonia, Viral - immunology Review SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Sex Characteristics Sex differences Target recognition Therapeutic applications tissue regeneration Viral diseases Viral infections Viruses |
| title | Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A38%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implications%20of%20Sex%20Differences%20in%20Immunity%20for%20SARS-CoV-2%20Pathogenesis%20and%20Design%20of%20Therapeutic%20Interventions&rft.jtitle=Immunity%20(Cambridge,%20Mass.)&rft.au=Bunders,%20Madeleine%20J.&rft.date=2020-09-15&rft.volume=53&rft.issue=3&rft.spage=487&rft.epage=495&rft.pages=487-495&rft.issn=1074-7613&rft.eissn=1097-4180&rft_id=info:doi/10.1016/j.immuni.2020.08.003&rft_dat=%3Cproquest_pubme%3E2442830439%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2442830439&rft_id=info:pmid/32853545&rft_els_id=S1074761320303368&rfr_iscdi=true |